- Proposed Tariffs Impact: President Trump’s proposal to impose tariffs of up to 250% on pharmaceuticals aims to shift production to the US but would likely increase drug prices for consumers, lead to shortages, and hinder long-term drug innovation.
- Market Dynamics: The pharmaceutical market consists of branded and generic drugs, with generics making up 90% of prescriptions but only 10% of spending. Tariffs would disproportionately affect generics, pushing up costs and potentially resulting in consumers opting for more expensive branded alternatives.
- Innovation and Supply Chain Concerns: Increased costs from tariffs could slow drug development, particularly for expensive orphan drugs. While firms may restructure to mitigate tariff impacts, this could lead to drug shortages in the short term, ultimately raising prices and risking consumer access to essential medications.
Source Tax Foundation
Latest Posts in "United States"
- California’s 11% Firearm Tax Is Almost Entirely Passed to Consumers, Study Finds
- Washington: Services Tied to Digital Automated Services Are Taxable as Retail Sales
- How Sales Tax Compliance Fuels Essential Services: Lessons from the Bay Area Transit Crisis
- Kilpatrick, Alabama Implements New Local Sales, Use, Rental, and Lodgings Taxes Starting March 2026
- US Court Orders Refund of Unlawful Tariffs After Supreme Court Ruling on IEEPA Duties
